Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome

Saudi Medical Journal

Volumn 28, Issue 7, 2007, Pages 1039-1043

  Sharquie, Khalifa E ^a   Al Bayatti, Ansam A ^a   Al Ajeel, Asmaa I ^a   Al Bahar, Awatif J ^b   Al Nuaimy, Adil A ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b Alwasl Hospital   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ACANTHOSIS NIGRICANS; ACNE; ADULT; AGE DISTRIBUTION; AMENORRHEA; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HORMONE DETERMINATION; HUMAN; IRAQ; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE TYPE ALOPECIA; MENSTRUAL CYCLE; OBESITY; OVARY POLYCYSTIC DISEASE; PALMOPLANTAR KERATODERMA; PROSPECTIVE STUDY; SALIVA LEVEL; SEBORRHEA; SKIN MANIFESTATION; SKIN ODOR; TESTOSTERONE BLOOD LEVEL; VAGINA CANDIDIASIS; ADOLESCENT; BLOOD; CHEMISTRY; PELVIS; SALIVA; SKIN DISEASE;

ADOLESCENT; ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; PELVIS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SALIVA; SKIN DISEASES; TESTOSTERONE;

EID: 34548446256     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M. Prevalence of Polycystic ovary syndrome in unselected black and white women of the southeastern United State, a prospective study. J Clin Endocrinal Metab 1998; 83: 3078-3082.
2. Norman RJ, Wu R, Stankiewicz MT. Polycystic ovary syndrome. Med J Aust 2004; 180: 132-137.
3. Hunter MH, Sterret JJ. Polycystic ovary syndrome: It's not just infertility. Am Fam Physician 2000; 80: 630-635.
4. Hopkinson Z, Sattar N, Fleming, R. Polycystic ovarian syndrome: The Metabolic Syndrome comes in Gynecology. Br Med J 1998; 317: 329-332.
5. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-47.
6. Dundaif A. Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release an gonadal steroid secretion in PCOS. J Clin Endocrinol Metab 1988; 60: 131-139.
7. Yildiz BO, Yarali, H, Oguz H. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2031-2036.
8. Richardson MR. Current perspectives in polycystic ovary syndrome. Am Fam Physician 2003; 15: 50-63.
9. Guzick DS. Polycystic Ovary Syndrome. Obstet Gynecol 2004; 103: 181-193.
10. Silfen ME, Denburg MR, Manibo AM. Early Endocrine, Metabolic and Sonographic Characteristics of polycystic ovary syndrome Comparison between Nonobese and Obese Adolescents. J Clin Endocrinol Metab 2003; 88: 4682-4688.
11. Franks S, polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.